Clinical Performance of the BD Onclarity Extended Genotyping Assay for the Management of Women Positive for Human Papillomavirus in Cervical Cancer Screening

Among women whose cervical specimens tested positive for high-risk human papillomaviruses (hrHPV) via the Hybrid Capture 2 assay in the Canadian Cervical Cancer Screening Trial (CCCaST), we assessed hrHPV genotype concordance between BD Onclarity HPV Assay and Roche's Linear Array, overall and...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2022-04, Vol.31 (4), p.851-857
Hauptverfasser:	Volesky, Karena D, Magnan, Sindy, Mayrand, Marie-Hélène, Isidean, Sandra D, El-Zein, Mariam, Comète, Emilie, Franco, Eduardo L, Coutlée, François
Format:	Artikel
Sprache:	eng
Schlagworte:	Alphapapillomavirus Canada Early Detection of Cancer Female Genotype Human papillomavirus 16 - genetics Human papillomavirus 18 - genetics Humans Papillomaviridae - genetics Papillomavirus Infections - diagnosis Sensitivity and Specificity Uterine Cervical Neoplasms
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!